Physician

Abayomi Adekunle Abimbola, M.D

According to 2025 Medicare claims, Abayomi Abimbola, M.D (NPI: 1851828073) practices family practice, with the plurality of this provider's patient population coming from Gratiot, MI. This provider's primary affiliated billing organization is MYMICHIGAN MEDICAL CENTER ALMA (NPI: 1801813373; TIN: 381437919) and primary practice location at 48801-1298. Abimbola is affiliated with the POM ACO (ACO ID: A1297) and Mosaic ACO (ACO ID: A5033), participating under the MSSP model.

Abimbola's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 118 traditional Medicare patients, billed 431 HCPCS/CPT codes, and received $30,700 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 4,543 prescription claims across 282 beneficiaries totaling $340,330 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 95 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $10,879 and ending at $30,700. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,444 to $340,330. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	56	178	$10,879
2021	129	443	$30,522
2022	93	361	$23,293
2023	137	535	$33,960
2024	118	431	$30,700

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	11	50	$1,444
2018	37	325	$20,335
2019	55	677	$63,273
2020	128	755	$58,251
2021	177	1,326	$107,561
2022	166	2,002	$215,606
2023	285	3,995	$328,391
2024	282	4,543	$340,330

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	19	$3,512
2023	N/R	41	$5,736
2024	N/R	95	$8,597

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	64	64	$122
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	90	164	$76
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	35	55	$55
G0008	Administration of influenza virus vaccine	15	15	$31
G0444	Annual depression screening, 5 to 15 minutes	23	23	$17

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	45	1,890	$39,949
Jardiance	Empagliflozin	34	1,862	$36,243
Rybelsus	Semaglutide	20	720	$23,081
Eliquis	Apixaban	15	900	$17,957
Xarelto	Rivaroxaban	23	930	$16,570

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	11	$4,077
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	30	$3,539
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	28	$602
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	12	$258
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	N	N/R	14	$120

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Abayomi Adekunle Abimbola, M.D?

Tedicare shows public-source Medicare data for Abayomi Adekunle Abimbola, M.D (NPI 1851828073), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abayomi Adekunle Abimbola, M.D have ACO affiliation data?

Abayomi Adekunle Abimbola, M.D is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297) and Mosaic ACO (MSSP, ACO ID A5033).

What billing organization is linked to Abayomi Adekunle Abimbola, M.D?

Abayomi Adekunle Abimbola, M.D is linked to MYMICHIGAN MEDICAL CENTER ALMA (billing NPI 1801813373) in the available physician profile data.

Does Abayomi Adekunle Abimbola, M.D have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.